Trevi Net Interest Income from 2010 to 2026
| TRVI Stock | USD 11.52 0.16 1.41% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter 1.4 M | Current Value 2.1 M | Quarterly Volatility 662.6 K |
Check Trevi Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Trevi Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 4.3 M, Discontinued Operations of 0.0 or Depreciation And Amortization of 177.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.95. Trevi financial statements analysis is a perfect complement when working with Trevi Therapeutics Valuation or Volatility modules.
Trevi | Net Interest Income | Build AI portfolio with Trevi Stock |
The Net Interest Income trend for Trevi Therapeutics offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Trevi Therapeutics is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Trevi Therapeutics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Trevi Therapeutics over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Trevi Therapeutics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Trevi Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Trevi Net Interest Income Regression Statistics
| Arithmetic Mean | (597,395) | |
| Coefficient Of Variation | (508.37) | |
| Mean Deviation | 2,588,170 | |
| Median | (1,192,000) | |
| Standard Deviation | 3,037,001 | |
| Sample Variance | 9.2T | |
| Range | 7.6M | |
| R-Value | 0.91 | |
| Mean Square Error | 1.8T | |
| R-Squared | 0.82 | |
| Slope | 545,195 | |
| Total Sum of Squares | 147.6T |
Trevi Net Interest Income History
About Trevi Therapeutics Financial Statements
Investors use fundamental indicators, such as Trevi Therapeutics' Net Interest Income, to determine how well the company is positioned to perform in the future. Although Trevi Therapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 4.1 M | 4.3 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Trevi Therapeutics Correlation against competitors. For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is there potential for Pharmaceuticals market expansion? Will Trevi introduce new products? Factors like these will boost the valuation of Trevi Therapeutics. If investors know Trevi will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Trevi Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Trevi Therapeutics requires distinguishing between market price and book value, where the latter reflects Trevi's accounting equity. The concept of intrinsic value - what Trevi Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Trevi Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Trevi Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Trevi Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Trevi Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.